| Report ID | 278232 |
| Drug Identification Number | 02546744 |
| Brand name | CYCLOPHOSPHAMIDE FOR INJECTION USP |
| Common or Proper name | cyclophosphamide for injection |
| Company Name | ANDONE PHARMACEUTICAL INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CYCLOPHOSPHAMIDE |
| Strength(s) | 2000MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | Each |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-02-19 |
| Actual start date | 2026-02-23 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-02-23 |
| Company comments | Backorder due to shortage of supply from other Canadian suppliers |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 2010 WINSTON PARK DRIVE OAKVILLE, ONTARIO CANADA L6H 5R7 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2026-02-23 | English | Compare |
| v4 | 2026-02-20 | French | Compare |
| v3 | 2026-02-20 | English | Compare |
| v2 | 2026-02-17 | French | Compare |
| v1 | 2026-02-17 | English | Compare |
Showing 1 to 5 of 5